Valuation: NeuroPace, Inc.

Market Cap 484M 419M 396M 360M 674M 46.43B 679M 4.73B 1.83B 23.55B 1.82B 1.78B 75.06B P/E 2026 *
-28.1x
P/E 2027 * -52.7x
Enterprise Value 507M 440M 415M 377M 707M 48.66B 711M 4.96B 1.92B 24.68B 1.91B 1.86B 78.66B EV / Sales 2026 *
5.06x
EV / Sales 2027 * 4.08x
Free-Float
82.62%
Yield 2026 *
-
Yield 2027 * -
1 day-1.05%
1 week-2.76%
Current month-3.75%
1 month-4.54%
3 months-6.13%
6 months-0.63%
Current year-8.68%
1 week 13.82
Extreme 13.815
14.66
1 month 13.56
Extreme 13.56
15.56
Current year 12.47
Extreme 12.47
19.6
1 year 9.22
Extreme 9.22
19.6
3 years 5.45
Extreme 5.45
19.6
5 years 1.22
Extreme 1.22
19.6
10 years 1.22
Extreme 1.22
27.38
Manager TitleAgeSince
Chief Executive Officer 58 2023-07-09
Director of Finance/CFO 53 2025-06-19
Chief Tech/Sci/R&D Officer - 2024-09-03
Director TitleAgeSince
Director/Board Member 57 2012-12-31
Chairman 84 1997-11-30
Director/Board Member 46 2021-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/3/26 Tax

Chief Executive Officer

-1,310 0.0038%
8/27/26 Tax

Chief Technology Officer

-358 0.0011%
8/27/26 Tax

Chief Executive Officer

-1,126 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%-2.76%+43.88%+62.82% 484M
+1.10%+7.06%+34.88%+25.78% 240B
-0.48%+1.71%+9.39%-18.37% 146B
+1.36%+8.22%-12.02%+29.35% 135B
+0.09%-2.34%-55.64%-16.99% 63.64B
+0.27%+0.16%-18.58%-15.00% 49.27B
+4.13%+3.60%+18.90%+21.97% 51.46B
+2.28%+6.18%+20.83%+32.59% 43.33B
+0.37%+3.42%+38.13%+51.79% 41.13B
+2.99%+11.67%+125.59%+56.64% 34.57B
Average +0.84%+2.57%+20.54%+23.06% 80.52B
Weighted average by Cap. +0.67%+4.31%+14.24%+15.27%

Financials

2026 *2027 *
Net sales 100M 86.9M 82.13M 74.56M 140M 9.62B 141M 981M 379M 4.88B 377M 368M 15.55B 123M 106M 100M 91.11M 171M 11.75B 172M 1.2B 463M 5.96B 460M 450M 19B
Net income -17.67M -15.31M -14.47M -13.14M -24.62M -1.69B -24.77M -173M -66.76M -860M -66.37M -64.9M -2.74B -9.25M -8.02M -7.58M -6.88M -12.89M -888M -12.97M -90.47M -34.96M -450M -34.75M -33.98M -1.43B
Net Debt 23.21M 20.12M 19.01M 17.26M 32.35M 2.23B 32.54M 227M 87.7M 1.13B 87.2M 85.26M 3.6B 16.02M 13.88M 13.12M 11.91M 22.32M 1.54B 22.46M 157M 60.52M 779M 60.17M 58.84M 2.48B
Logo NeuroPace, Inc.
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.
Employees
220
Date Price Change Volume
26-09-16 US$14.10 -1.05% 116,144
26-09-15 US$14.25 -2.33% 96,844
26-09-14 US$14.59 +3.92% 125,888
26-09-11 US$14.04 +1.23% 107,481
26-09-10 US$13.87 -4.34% 73,028
Trader
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
14.10USD
Average target price
20.22USD
Spread / Average Target
+43.42%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NPCE Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!